BCL2L1 and neoplasm: Among all treatments tested in the MGT4 cell line (single or combined drugs), we uncovered that the simultaneous inhibition of BCL‐XL and WEE1 drastically reduced tumor cell viability (Figure S5a,b, Supporting Information).